The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes
Open accessAbstract
AtT-20 cells expressing the wild-type kappa opioid receptor (KOR) increased phospho-p38 MAPK following treatment with the kappa agonist U50,488. The increase was blocked by the kappa antagonist norbinaltorphimine and not evident in untransfected cells. In contrast, U50,488 treatment of AtT-20 cells expressing KOR having alanine substituted for serine-369 (KSA) did not increase phospho-p38. Phosphorylation of serine 369 in the KOR carboxyl terminus by G-protein receptor kinase 3 (GRK3) was previously shown to be required for receptor desensitization, and the results suggest that p38 MAPK activation by KOR may require arrestin recruitment. This hypothesis was tested by transfecting arrestin3-(R170E), a dominant positive form of arrestin that does not require receptor phosphorylation for activation. AtT-20 cells expressing both KSA and arrestin3-(R170E) responded to U50,488 treatment with an increase in phospho-p38 consistent with the hypothesis. Primary cultured astrocytes (glial fibrillary acidic protein-positive) and neurons (gamma-aminobutyric acid-positive) isolated from mouse striata also responded to U50,488 by increasing phospho-p38 immunolabeling. p38 activation was not evident in either striatal astrocytes or neurons isolated from KOR knock-out mice or GRK3 knock-out mice. Astrocytes pretreated with small interfering RNA for arrestin3 were also unable to activate p38 in response to U50,488 treatment. Furthermore, in striatal neurons, the kappa-mediated phospho-p38 labeling was colocalized with arrestin3. These findings suggest that KOR may activate p38 MAPK in brain by a GRK3 and arrestin-dependent mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
MAPK cascade signalling and synaptic plasticity
Thomas, G. M., & Huganir, R. L. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1346 · Cited by 1,454
Control of Synapse Number by Glia
Ullian, E. M., Sapperstein, S. K., Christopherson, K. S., & Barres, B. A. (2001) · Science · doi:10.1126/science.291.5504.657 · Cited by 1,380
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,197
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & Goldstein, A. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,168
Self-citationG-protein-coupled receptors and signaling networks: emerging paradigms
Marinissen, M. J., & Gutkind, J. S. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01678-3 · Cited by 1,049
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041604898 · Cited by 831
β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3
McDonald, P. H., Chow, C.-W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F.-T., Davis, R. J., & Lefkowitz, R. J. (2000) · Science · doi:10.1126/science.290.5496.1574 · Cited by 819
International Union of Pharmacology. XII. Classification of opioid receptors
Dhawan, B., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P., Portoghese, P., & Hamon, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06958-3 · Cited by 732
Linkage of G Protein-Coupled Receptors to the MAPK Signaling Pathway Through PI 3-Kinase γ
Lopez-Ilasaca, M., Crespo, P., Pellici, P. G., Gutkind, J. S., & Wetzker, R. (1997) · Science · doi:10.1126/science.275.5298.394 · Cited by 670
The stress-activated protein kinase pathways
Tibbles, L. A., & Woodgett, J. R. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050369 · Cited by 643
The role of neuroinflammation and neuroimmune activation in persistent pain
DeLeo, J. A., & Yezierski, R. P. (2001) · Pain · doi:10.1016/s0304-3959(00)00490-5 · Cited by 639
Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptors
Pierce, K. L., & Lefkowitz, R. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094577 · Cited by 476
Isolation and culture of adult rat hippocampal neurons
Brewer, G. J. (1997) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(96)00136-7 · Cited by 447
McLaughlin, J. P., Marton-Popovici, M., & Chavkin, C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05674.2003 · Cited by 430
Self-citationSun, Y., Cheng, Z., Ma, L., & Pei, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207294200 · Cited by 382
Mócsai, A., Jakus, Z., Vántus, T., Berton, G., Lowell, C. A., & Ligeti, E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4321 · Cited by 287
Regulation of Mitogen-Activated Protein Kinase Signaling Networks by G Protein-Coupled Receptors
Gutkind, J. S. (2000) · Science's STKE · doi:10.1126/stke.2000.40.re1 · Cited by 264
Pleiotropic Coupling of G Protein-coupled Receptors to the Mitogen-activated Protein Kinase Cascade
Della Rocca, G. J., Maudsley, S., Daaka, Y., Lefkowitz, R. J., & Luttrell, L. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13978 · Cited by 260
Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3–CA1 synapses
Bolshakov, V. Y., Carboni, L., Cobb, M. H., Siegelbaum, S. A., & Belardetti, F. (2000) · Nature Neuroscience · doi:10.1038/80624 · Cited by 220
Kovoor, A., Celver, J., Abdryashitov, R. I., Chavkin, C., & Gurevich, V. V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.6831 · Cited by 212
Self-citationChavkin, C., Sud, S., Jin, W., Stewart, J., Zjawiony, J. K., Siebert, D. J., Toth, B. A., Hufeisen, S. J., & Roth, B. L. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059394 · Cited by 210
Self-citationThe discovery of potent cRaf1 kinase inhibitors
Lackey, K., Cory, M., Davis, R., Frye, S. V., Harris, P. A., Hunter, R. N., Jung, D. K., McDonald, O. B., McNutt, R. W., Peel, M. R., et al. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00668-x · Cited by 206
Wang, Y., Tang, K., Inan, S., Siebert, D., Holzgrabe, U., Lee, D. Y. W., Huang, P., Li, J.-G., Cowan, A., & Liu-Chen, L.-Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073668 · Cited by 191
Thompson, A. C., Zapata, A., Justice, J. B., Vaughan, R. A., Sharpe, L. G., & Shippenberg, T. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09333.2000 · Cited by 175
Belcheva, M. M., Clark, A. L., Haas, P. D., Serna, J. S., Hahn, J. W., Kiss, A., & Coscia, C. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502593200 · Cited by 173
Xu, M., Petraschka, M., McLaughlin, J. P., Westenbroek, R. E., Caron, M. G., Lefkowitz, R. J., Czyzyk, T. A., Pintar, J. E., Terman, G. W., & Chavkin, C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5552-03.2004 · Cited by 172
Self-citationIntegration of Signals from Receptor Tyrosine Kinases and G Protein-Coupled Receptors
Lowes, V. L., Ip, N. Y., & Wong, Y. H. (2002) · Neurosignals · doi:10.1159/000057317 · Cited by 144
Conservation of the Phosphate-sensitive Elements in the Arrestin Family of Proteins
Celver, J. P., Vishnivetskiy, S. A., Chavkin, C., & Gurevich, V. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107400200 · Cited by 141
Self-citationNagao, M., Yamauchi, J., Kaziro, Y., & Itoh, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.22892 · Cited by 124
β-Arrestin 2-Dependent Angiotensin II Type 1A Receptor-Mediated Pathway of Chemotaxis
Hunton, D. L., Barnes, W. G., Kim, J., Ren, X.-R., Violin, J. D., Reiter, É., Milligan, G., Patel, D. D., & Lefkowitz, R. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006270 · Cited by 123
McLaughlin, J. P., Xu, M., Mackie, K., & Chavkin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304022200 · Cited by 94
Self-citationBohn, L., Belcheva, M. M., & Coscia, C. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740564.x · Cited by 89
Appleyard, S. M., Celver, J. P., Pineda, V. V., Kovoor, A., Wayman, G. A., & Chavkin, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23802 · Cited by 84
Self-citationRonken, E., Mulder, A. H., & Schoffelmeer, A. N. M. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09797.x · Cited by 78
Preferential Interaction between the Dopamine D2 Receptor and Arrestin2 in Neostriatal Neurons
Macey, T. A., Gurevich, V. V., & Neve, K. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001495 · Cited by 75
Self-citationKam, A. Y. F., Chan, A. S. L., & Wong, Y. H. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065078 · Cited by 44
Functional analysis of cloned opioid receptors in transfected cell lines
Piros, E. T., Hales, T. G., & Evans, C. J. (1996) · Neurochemical Research · doi:10.1007/bf02532368 · Cited by 41
Cited by
β-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397
Molecular mechanisms of opioid receptor-dependent signaling and behavior
Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067
Self-citationThe Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601
Self-citationThe dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544
Self-citationTherapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Metadata
- Authors
- Bruchas, M. R., Macey, T. A., Lowe, J. D., & Chavkin, C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 281
- Issue
- 26
- Pages
- 18081-18089
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2123895632
- Cited by
- 258
- References
- 42
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.